MYLAN-BROMAZEPAM
MYLAN-BROMAZEPAM
Discontinued
DIN Number
02192705
Drug Class
Human
Market Date
Dec 31, 1995
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02192705
AIG Number0114488002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA08 BROMAZEPAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
BROMAZEPAMActive
Strength: 1.5 MG
Monograph: BROMAZEPAM